Drug manufacturing major Ranbaxy Laboratories Limited on Thursday reported a 168 % jump in the net profit for the third quarter of 2010 ending Sep 30 at Rs.308 crore as against Rs.115 crore during the corresponding period last year.
The total income of the company for the quarter stood at Rs.2,138 crore against Rs.1,902 crore during the like period of last year, it said in a regulatory filing.
"Our key markets continued to perform well, attributable in large measure to balanced sales across geographies. This has also been aided by the favourable forex movement," said Ranbaxy's Managing Director Arun Sawhney.
At the Bombay Stock Exchange, the shares of the company were trading 3.83 % lower at Rs.580.9.